This page lists all known medications that could potentially lead to 'Aggravated Angina Pectoris' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
Most patients with coronary artery disease (CAD) and chronic stable angina will obtain complete relief of symptoms with percutaneous coronary intervention (PCI). However, some chronic angina patients ...
Angina pectoris is a debilitating indication of thepresence of ischemic heart disease that affects millionsof Americans. Although a number of pharmacologictreatments are available, the annual numberof ...
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Angina Pectoris Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global landscape of angina pectoris drugs is ...
Background: There is speculation that women and South Asian people are more likely than men and white people to report atypical angina and that they are less likely to undergo invasive management of ...
BECAUSE angina pectoris is a consequence of inadequate myocardial oxygenation, ideal therapy for this incapacitating symptom would be directed toward both increasing coronary blood flow and decreasing ...
Background A 50-year-old woman presented with recurrent episodes of unstable angina pectoris refractory to vasodilator treatment. Relevant coronary stenoses were excluded by coronary angiography and ...
Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...
The most recent data comes from the Efficacy of Ranolazine in Chronic Angina (ERICA) trial, published in the August 1, 2006, issue of JACC. 17 Stable patients with coronary disease and ≥3 anginal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results